Target intelligence / Profile preview

DEAD-box helicase 31 (DDX31)

Target
DDX31
Molecular classification
Enzyme, ATP-dependent RNA helicase, ATP-dependent DNA helicase, DEAD-box protein, RNA-binding protein
01

Overview

DEAD-box helicase 31 (DDX31) is an ATP-dependent RNA and DNA helicase enzyme characterized by the conserved DEAD (Asp-Glu-Ala-Asp) motif. It belongs to the DEAD-box family, which is the largest group of RNA helicases and is structurally defined by two RecA-like domains connected by a flexible linker and conserved sequence motifs for RNA binding, ATP binding, and ATP hydrolysis[1][3][4][6]. DEAD-box helicases, including DDX31, act through unwinding short RNA duplexes and modulating secondary structure in a non-processive, non-sequence-specific manner, frequently acting as part of ribonucleoprotein complexes[4][6]. DDX31 plays a role in ribosome biogenesis and has been reported to regulate the p53-HDM2 pathway and rRNA transcription via interaction with nucleophosmin 1 (NPM1), particularly in the context of renal cell carcinoma[1][7]. While its full, unique functions remain undetermined, family members influence translation initiation, RNA splicing, cell growth, embryogenesis, and spermatogenesis. No approved drugs specifically target DDX31, nor is it established as a clinical biomarker or drug safety concern. However, its potential as a cancer-related therapeutic target and regulator of critical cellular processes makes it of growing investigational interest[1][3][7].

Other names
PPP1R25DEAD (Asp-Glu-Ala-Asp) box polypeptide 31DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 31protein phosphatase 1 regulatory subunit 25ATP-dependent DNA helicase DDX31DEAD box protein 31helicainprobable ATP-dependent RNA helicase DDX31
02

Mechanism of action

null (no drugs are reported to specifically target DDX31, but general mechanisms for DEAD-box helicases include inhibition of ATPase or helicase activity, affecting ribosome biogenesis and RNA processing)[1][4][6][7]

03

Biological functions

Ribosome biogenesis (especially through interaction with NPM1 and regulation of TP53/p53)Regulation of RNA secondary structure (including translation initiation, nuclear and mitochondrial splicing, ribosome and spliceosome assembly)Nucleic acid bindingATP-dependent unwinding of RNA and DNA
04

Disease associations

Cancer (specifically implicated in renal cell carcinoma via regulation of p53-HDM2 pathway and rRNA gene transcription)Other (general involvement in cellular growth and division, potential roles in embryogenesis and spermatogenesis)

Beyond the preview

Go deeper on DEAD-box helicase 31 (DDX31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEAD-box helicase 31 (DDX31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call